Transplantation and Cellular Therapy | 2023
Donor-derived malignancy and transplantation morbidity: Risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation.
Williams LS, Williams KM, Gillis N, Bolton K, Damm F, Deuitch NT, Farhadfar N, Gergis U, Keel SB, Michelis FV, Panch SR, Porter CC, Sucheston-Campbell L, Tamari R, Stefanski HE, Godley LA, Lai C
PubMed
PMID: 37913908
Abstract
Related Articles
CIBMTR Study #: CIBMTR_NA